A new generation fatty acid amide hydrolase inhibitor protects against kainate-induced excitotoxicity

Journal of Molecular Neuroscience

Volumn 43, Issue 3, 2011, Pages 493-502

  Naidoo, Vinogran ^a   Nikas, Spyros P ^b   Karanian, David A ^c   Hwang, Jeannie ^a,c   Zhao, Jianhong ^b   Wood, JodiAnne T ^b   Alapafuja, Shakiru O ^d   Vadivel, Subramanian K ^b   Butler, David ^c,e   Makriyannis, Alexandros ^b   Bahr, Ben A ^a,b,c  

^a UNIVERSITY OF NORTH CAROLINA AT PEMBROKE   (United States)

^b NORTHEASTERN UNIVERSITY   (United States)

^c UNIVERSITY OF CONNECTICUT   (United States)

^d MAKScientific LLC   (United States)

^e BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

AM5206; Endocannabinoid system; Excitotoxicity; Hippocampus; Neuroprotection

Indexed keywords

ACYLGLYCEROL LIPASE; ALANINE AMINOTRANSFERASE; AM 5206; ANANDAMIDE; FATTY ACID AMIDASE; FATTY ACID AMIDASE INHIBITOR; KAINIC ACID; LACTATE DEHYDROGENASE; UNCLASSIFIED DRUG; UREA;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG BRAIN LEVEL; ENZYME ACTIVITY; ENZYME ASSAY; EXCITOTOXICITY; FLUOROMETRY; IMMUNOBLOTTING; IN VITRO STUDY; IN VIVO STUDY; INHIBITION KINETICS; MASS SPECTROMETRY; NERVE DEGENERATION; NEUROPROTECTION; NEWBORN; NONHUMAN; RAT; SEIZURE; UREA NITROGEN BLOOD LEVEL;

AMIDOHYDROLASES; ANIMALS; ARACHIDONIC ACIDS; ENDOCANNABINOIDS; HIPPOCAMPUS; KAINIC ACID; PHENYL ETHERS; POLYUNSATURATED ALKAMIDES; RATS; RATS, SPRAGUE-DAWLEY; SEIZURES; TISSUE CULTURE TECHNIQUES;

RATTUS;

EID: 79955849920     PISSN: 08958696     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12031-010-9472-4     Document Type: Article

References (61)

1. Araujo BH, Torres LB, Cossa AC, Naffah-Mazzacoratti Mda G, Cavalheiro EA (2010) Hippocampal expression and distribution of CB1 receptors in the Amazonian rodent Proechimys: an animal model of resistance to epilepsy. Brain Res 1335:35-40
2. Arida RM, Scorza FA, de Amorim CR, Cavalheiro EA (2005) Proechimys guyannensis: an animal model of resistance to epilepsy. Epilepsia 46(Suppl 5):189-197 (Pubitemid 40962144)
3. Bahr BA (1995) Long-term hippocampal slices: a model system for investigating synaptic mechanisms and pathologic processes. J Neurosci Res 42:294-305
4. Bahr BA, Abai B, Gall CM, Vanderklish PW, Hoffman KB, Lynch G (1994) Induction of β-amyloid-containing polypeptides in hippocampus: evidence for a concomitant loss of synaptic proteins and interactions with an excitotoxin. Exp Neurol 129:81-94
5. Bahr BA, Bendiske J, Brown QB, Munirathinam S, Caba E, Rudin M, Urwyler S, Sauter A, Rogers G (2002) Survival signaling and selective neuroprotection through glutamatergic transmission. Exp Neurol 174:37-47 (Pubitemid 34218907)
6. Bahr BA, Karanian DA, Makanji SS, Makriyannis A (2006) Targeting the endocannabinoid system in treating brain disorders. Expert Opin Investig Drugs 15:351-365
7. Basavarajappa BS (2007) Critical enzymes involved in endocannabinoid metabolism. Protein Pept Lett 14:237-246
8. Bonde C, Noraberg J, Noer H, Zimmer J (2005) Ionotropic glutamate receptors and glutamate transporters are involved in necrotic neuronal cell death induced by oxygen-glucose deprivation of hippocampal slice cultures. Neuroscience 136:779-794 (Pubitemid 41774724)
9. Caba E, Bahr BA (2004) Biphasic NF-κB activation in the excitotoxic hippocampus. Acta Neuropathol 108:173-182 (Pubitemid 39199507)
10. Cippitelli A, Cannella N, Braconi S, Duranti A, Tontini A, Bilbao A, Defonseca FR, Piomelli D, Ciccocioppo R (2008) Increase of brain endocannabinoid anandamide levels by FAAH inhibition and alcohol abuse behaviours in the rat. Psychopharmacology (Berl) 198:449-460
11. Clement AB, Hawkins EG, Lichtman AH, Cravatt BF (2003) Increased seizure susceptibility and proconvulsant activity of anandamide in mice lacking fatty acid amide hydrolase. J Neurosci 23:3916-3923 (Pubitemid 36958497)
12. Coomber B, O'Donoghue MF, Mason R (2008) Inhibition of endocannabinoid metabolism attenuates enhanced hippocampal neuronal activity induced by kainic acid. Synapse 62:746-755
13. Cravatt BF, Demarest K, Patricelli MP, Bracey MH, Giang DK, Martin BR, Lichtman AH (2001) Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase. Proc Natl Acad Sci USA 98:9371-9376 (Pubitemid 32743923)
14. Deadwyler SA, Hampson RE, Bennett BA, Edwards TA, Mu J, Pacheco MA, Ward SJ, Childers SR (1993) Cannabinoids modulate potassium current in cultured hippocampal neurons. Recept Channels 1:121-134
15. Deadwyler SA, Hampson RE, Mu J, Whyte A, Childers S (1995) Cannabinoids modulate voltage sensitive potassium A-current in hippocampal neurons via a cAMP-dependent process. J Pharmacol Exp Ther 273:734-743
16. Di Marzo V (2008) Endocannabinoids: synthesis and degradation. Rev Physiol Biochem Pharmacol 160:1-24
17. Egertova M, Giang DK, Cravatt BF, Elphick MR (1998) A new perspective on cannabinoid signalling: complementary localization of fatty acid amide hydrolase and the CB1 receptor in rat brain. Proc Biol Sci 265:2081-2085 (Pubitemid 28502544)
18. Egertova M, Cravatt BF, Elphick MR (2003) Comparative analysis of fatty acid amide hydrolase and cb1 cannabinoid receptor expression in the mouse brain: evidence of a widespread role for fatty acid amide hydrolase in regulation of endocannabinoid signaling. Neuroscience 119:481-496 (Pubitemid 36588826)
19. Fernandez-Ruiz J, Garcia C, Sagredo O, Gomez-Ruiz M, de Lago E (2010) The endocannabinoid system as a target for the treatment of neuronal damage. Expert Opin Ther Targets 14:387-404
20. Galve-Roperh I, Rueda D, Gomez del Pulgar T, Velasco G, Guzman M (2002) Mechanism of extracellular signal-regulated kinase activation by the CB(1) cannabinoid receptor. Mol Pharmacol 62:1385-1392 (Pubitemid 35403833)
21. Gomez del Pulgar T, Velasco G, Guzman M (2000) The CB1 cannabinoid receptor is coupled to the activation of protein kinase B/Akt. Biochem J 347:369-373 (Pubitemid 30229383)
22. Hajos N, Katona I, Naiem SS, MacKie K, Ledent C, Mody I, Freund TF (2000) Cannabinoids inhibit hippocampal GABAergic transmission and network oscillations. Eur J Neurosci 12:3239-3249
23. Hansen HH, Schmid PC, Bittigau P, Lastres-Becker I, Berrendero F, Manzanares J, Ikonomidou C, Schmid HH, Fernandez-Ruiz JJ, Hansen HS (2001) Anandamide, but not 2-arachidonoylglycerol, accumulates during in vivo neurodegeneration. J Neurochem 78:1415-1427 (Pubitemid 32899773)
24. Hwang J, Adamson C, Butler D, Janero DR, Makriyannis A, Bahr BA (2010) Enhancement of endocannabinoid signaling by fatty acid amide hydrolase inhibition: a neuroprotective therapeutic modality. Life Sci 86:615-623
25. Izzo AA, Sharkey KA (2010) Cannabinoids and the gut: new developments and emerging concepts. Pharmacol Ther 126:21-38
26. Janero DR, Vadivel SK, Makriyannis A (2009) Pharmacotherapeutic modulation of the endocannabinoid signalling system in psychiatric disorders: drug-discovery strategies. Int Rev Psychiatry 21:122-133
27. Jourdi H, Hamo L, Oka T, Seegan A, Baudry M (2009) BDNF mediates the neuroprotective effects of positive AMPA receptor modulators against MPP+-induced toxicity in cultured hippocampal and mesencephalic slices. Neuropharmacology 56:876-885
28. Karanian DA, Brown QB, Makriyannis A, Bahr BA (2005a) Blocking cannabinoid activation of FAK and ERK1/2 compromises synaptic integrity in hippocampus. Eur J Pharmacol 508:47-56 (Pubitemid 40169901)
29. Karanian DA, Brown QB, Makriyannis A, Kosten TA, Bahr BA (2005b) Dual modulation of endocannabinoid transport and fatty acid amide hydrolase protects against excitotoxicity. J Neurosci 25:7813-7820 (Pubitemid 41208653)
30. Karanian DA, Karim SL, Wood JT, Williams JS, Lin S, Makriyannis A, Bahr BA (2007) Endocannabinoid enhancement protects against kainic acid-induced seizures and associated brain damage. J Pharmacol Exp Ther 322:1059-1066 (Pubitemid 47295815)
31. Kathuria S, Gaetani S, Fegley D, Valino F, Duranti A, Tontini A, Mor M, Tarzia G, La Rana G, Calignano A, Giustino A, Tattoli M, Palmery M, Cuomo V, Piomelli D (2003) Modulation of anxiety through blockade of anandamide hydrolysis. Nat Med 9:76-81 (Pubitemid 36098263)
32. Khaspekov LG, Brenz Verca MS, Frumkina LE, Hermann H, Marsicano G, Lutz B (2004) Involvement of brain-derived neurotrophic factor in cannabinoid receptor-dependent protection against excitotoxicity. Eur J Neurosci 19:1691-1698 (Pubitemid 38482557)
33. Kreitzer AC, Regehr WG (2001) Retrograde inhibition of presynaptic calcium influx by endogenous cannabinoids at excitatory synapses onto Purkinje cells. Neuron 29:717-727 (Pubitemid 32323944)
34. Kunos G, Osei-Hyiaman D, Batkai S, Sharkey KA, Makriyannis A (2009) Should peripheral CB(1) cannabinoid receptors be selectively targeted for therapeutic gain? Trends Pharmacol Sci 30:1-7
35. Lastres-Becker I, Hansen HH, Berrendero F, De Miguel R, Perez-Rosado A, Manzanares J, Ramos JA, Fernandez-Ruiz J (2002) Alleviation of motor hyperactivity and neurochemical deficits by endocannabinoid uptake inhibition in a rat model of Huntington's disease. Synapse 44:23-35 (Pubitemid 34174375)
36. Maccarrone M, Gubellini P, Bari M, Picconi B, Battista N, Centonze D, Bernardi G, Finazzi-Agro A, Calabresi P (2003) Levodopa treatment reverses endocannabinoid system abnormalities in experimental Parkinsonism. J Neurochem 85:1018-1025 (Pubitemid 36578633)
37. Marsicano G, Goodenough S, Monory K, Hermann H, Eder M, Cannich A, Azad SC, Cascio MG, Gutierrez SO, van der Stelt M, Lopez- Rodriguez ML, Casanova E, Schutz G, Zieglgansberger W, Di Marzo V, Behl C, Lutz B (2003) CB1 cannabinoid receptors and on-demand defense against excitotoxicity. Science 302:84-88 (Pubitemid 37210691)
38. Molina-Holgado F, Pinteaux E, Heenan L, Moore JD, Rothwell NJ, Gibson RM (2005) Neuroprotective effects of the synthetic cannabinoid HU-210 in primary cortical neurons are mediated by phosphatidylinositol 3-kinase/AKT signaling. Mol Cell Neurosci 28:189-194 (Pubitemid 39656022)
39. Morozov YM, Ben-Ari Y, Freund TF (2004) The spatial and temporal pattern of fatty acid amide hydrolase expression in rat hippocampus during postnatal development. Eur J Neurosci 20:459-466 (Pubitemid 38969630)
40. Ohno-Shosaku T, Maejima T, Kano M (2001) Endogenous cannabinoids mediate retrograde signals from depolarized postsynaptic neurons to presynaptic terminals. Neuron 29:729-738 (Pubitemid 32323945)
41. Onaivi ES (2009) Cannabinoid receptors in brain: pharmacogenetics, neuropharmacology, neurotoxicology, and potential therapeutic applications. Int Rev Neurobiol 88:335-369
42. Panikashvili D, Simeonidou C, Ben-Shabat S, Hanus L, Breuer A, Mechoulam R, Shohami E (2001) An endogenous cannabinoid (2-AG) is neuroprotective after brain injury. Nature 413:527-531 (Pubitemid 32938751)
43. Parmentier-Batteur S, Jin K, Mao XO, Xie L, Greenberg DA (2002) Increased severity of stroke in CB1 cannabinoid receptor knock-out mice. J Neurosci 22:9771-9775 (Pubitemid 35332860)
44. Patricelli MP, Lashuel HA, Giang DK, Kelly JW, Cravatt BF (1998) Comparative characterization of a wild type and transmembrane domain-deleted fatty acid amide hydrolase: identification of the transmembrane domain as a site for oligomerization. Biochemistry 37:15177-15187
45. Pavlopoulos S, Thakur GA, Nikas SP, Makriyannis A (2006) Cannabinoid receptors as therapeutic targets. Curr Pharm Res 12:1751-1769
46. Ramarao MK, Murphy EA, Shen MW, Wang Y, Bushell KN, Huang N, Pan N, Williams C, Clark JD (2005) A fluorescence-based assay for fatty acid amide hydrolase compatible with high-throughput screening. Anal Biochem 343:143-151 (Pubitemid 40978619)
47. Rodriguez de Fonseca F, Del Arco I, Bermudez-Silva FJ, Bilbao A, Cippitelli A, Navarro M (2005) The endocannabinoid system: physiology and pharmacology. Alcohol Alcohol 40:2-14
48. Ryzhikov S, Bahr BA (2008) Gephyrin alterations due to protein accumulation stress are reduced by the lysosomal modulator Z-Phe-Ala- diazomethylketone. J Mol Neurosci 34:131-139 (Pubitemid 351903616)
49. Sagar DR, Jhaveri MD, Richardson D, Gray RA, de Lago E, Fernandez-Ruiz J, Barrett DA, Kendall DA, Chapman V (2010) Endocannabinoid regulation of spinal nociceptive processing in a model of neuropathic pain. Eur J Neurosci 31:1414-1422
50. Straiker A, Mackie K (2009) Cannabinoid signaling in inhibitory autaptic hippocampal neurons. Neuroscience 163:190-201
51. Tsou K, Mackie K, Sanudo-Pena MC, Walker JM (1999) Cannabinoid CB1 receptors are localized primarily on cholecystokinin-containing GABAergic interneurons in the rat hippocampal formation. Neuroscience 93:969-975 (Pubitemid 29341643)
52. Vanderklish PW, Bahr BA (2000) The pathogenic activation of calpain: a marker and mediator of cellular toxicity and disease states. Int J Exp Pathol 81:323-339 (Pubitemid 32061651)
53. Viveros MP, de Fonseca FR, Bermudez-Silva FJ, McPartland JM (2008) Critical role of the endocannabinoid system in the regulation of food intake and energymetabolism, with phylogenetic, developmental, and pathophysiological implications. Endocr Metab Immune Disord Drug Targets 8:220-230
54. Vornov JJ, Tasker RC, Coyle JT (1994) Delayed protection by MK-801 and tetrodotoxin in a rat organotypic hippocampal culture model of ischemia. Stroke 25:457-464
55. Wang Q, Yu S, Simonyi A, Sun GY, Sun AY (2005) Kainic acid-mediated excitotoxicity as a model for neurodegeneration. Mol Neurobiol 31:3-16 (Pubitemid 41271190)
56. Williams J, Wood J, Pandarinathan L, Karanian DA, Bahr BA, Vouros P, Makriyannis A (2007) Quantitative method for the profiling of the endocannabinoid metabolome by LC-atmospheric pressure chemical ionization-MS. Anal Chem 79:5582-5593 (Pubitemid 47229803)
57. Wilson RI, Kunos G, Nicoll RA (2001) Presynaptic specificity of endocannabinoid signaling in the hippocampus. Neuron 31:453-462 (Pubitemid 32778563)
58. Wolf SA, Bick-Sander A, Fabel K, Leal-Galicia P, Tauber S, Ramirez-Rodriguez G, Muller A, Melnik A, Waltinger TP, Ullrich O, Kempermann G (2010) Cannabinoid receptor CB1 mediates baseline and activity-induced survival of new neurons in adult hippocampal neurogenesis. Cell Commun Signal 8:1-14
59. Wood JT, Williams JS, Pandarinathan L, Courville A, Keplinger MR, Janero DR, Vouros P, Makriyannis A, Lammi-Keefe CJ (2008) Comprehensive profiling of the human circulating endocannabinoid metabolome: clinical sampling and sample storage parameters. Clin Chem Lab Med 46:1289-1295
60. Wood JT, Williams JS, Pandarinathan L, Janero DR, Lammi-Keefe CJ, Makriyannis A (2010) Dietary docosahexaenoic acid supplementation alters select physiological endocannabinoid-system metabolites in brain and plasma. J Lipid Res 51:1416-1423
61. Zvonok N, Williams J, Johnston M, Pandarinathan L, Janero DR, Li J, Krishnan SC, Makriyannis A (2008) Full mass spectrometric characterization of human monoacylglycerol lipase generated by large-scale expression and single-step purification. J Proteome Res 7:2158-2164